Lung Kwong Group Limited filed with Hong Kong Trading and Settlement Limited on 3 June 2024 with Hong Kong Trading and Settlement Limited, reporting the changes in the company's share capital as of 31 May 2024. The report shows that the company's regulary/registered share capital and issued shares remained unchanged during the reporting period. The number of ordinary shares remained at 100,000,000,000 shares, with a face value of HK$0.1 per share and a total share capital of HK$10,000,000,000. In addition, the Company's share option plan adopted on November 18, 2013 has expired on November 17, 2023, and no further share purchase rights have been granted. During the reporting period, some of the stock options under the stock option plan expired, resulting in a reduction in the number of stock options, but without affecting the number of shares issued in the company.

Lung Kwong Group Limited filed with Hong Kong Trading and Settlement Limited on 3 June 2024 with Hong Kong Trading and Settlement Limited, reporting the changes in the company's share capital as of 31 May 2024. The report shows that the company's regulary/registered share capital and issued shares remained unchanged during the reporting period. The number of ordinary shares remained at 100,000,000,000 shares, with a face value of HK$0.1 per share and a total share capital of HK$10,000,000,000. In addition, the Company's share option plan adopted on November 18, 2013 has expired on November 17, 2023, and no further share purchase rights have been granted. During the reporting period, some of the stock options under the stock option plan expired, resulting in a reduction in the number of stock options, but without affecting the number of shares issued in the company.